Tranzyme to Study Primate Models of Human Disease with SNBL

[Guest guest]

http://www.localtechwire.com/article.cfm?u=7803

 

Tranzyme to Study Primate Models of Human Disease with

SNBL

Special To LTW

 

RESEARCH TRIANGLE PARK & #12539;Tranzyme Pharma has

entered a joint research collaboration with Shin

Nippon Biomedical Laboratories (SNBL), Japan's largest

CRO, to develop non-human primate models of human

diseases for medical research and drug discovery.

 

Under the terms of the deal, Tranzyme will provide

SNBL access to its functional biology and gene

delivery technology (TExT). SNBL will apply the

technology to ex vivo and in vivo applications using

cells and tissues from non-human primates.

 

SNBL will provide research support for the

collaboration and will have an option to license

Tranzyme's technology for commercial purposes.

Additional financial terms of the collaboration were

not disclosed.

 

Established in 1957, SNBL has an international

presence with state-of-the-art facilities in Japan,

U.S., Europe and China. In June 2003, SNBL made a

strategic equity investment in Tranzyme.

 

" We are pleased to continue to grow our relationship

with SNBL, " said Vipin Garg, president and CEO of

Tranzyme. " This collaboration is expected to provide

models of human diseases that are otherwise not

available, resulting ultimately in the discovery of

new pharmaceuticals. Furthermore, these unique animal

models will provide enhanced efficiency for ongoing

drug discovery efforts. "

 

Tranzyme: www.tranzyme.com

 

Posted: 04/15/2004 09:55 AM

 

 

 

 

 

 

 

 

Tax Center - File online by April 15th

http://taxes./filing.html